Search

everythinglearnresearchcommunity

for

Search:↓

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Quality pharmaceutical care is crucial for safe and effective use of vitamin-mineral supplements during pregnancy and breastfeeding.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

Researchers found that certain RNA circles in the brain are linked to disease risk, but their exact role in disease is still unknown.

Skin symptoms can indicate endocrine disorders and have various treatments.